Baldry Mark

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$19,251.91
Insider Sells Quantity
3
Insider Sells Sum
$27,234.67

Insider Activity of Baldry Mark

According to the SEC Form 4 filings, Baldry Mark, being in a position of

  1. Chief Commercial Officer at X4 Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 35050 shares for $19,252, and sold 40286 shares for $19,747,
    over all time since 2023-11-01, has bought 35050 shares for $19,252, and sold 50543 shares for $27,235.

The largest purchase of all time was on 2024-05-17 and amounted to 21646 shares of X4 Pharmaceuticals, Inc. for $14,654.

The largest sale of all time was on 2025-01-24 and amounted to 29159 shares of X4 Pharmaceuticals, Inc. for $13,241.

Biography of Baldry Mark

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$19,252250
Sells
$19,747250

Comparison of Insiders on Amount of Buys and Sells

2025-01-24SaleX4 Pharmaceuticals, Inc.
XFOR
Chief Commercial Officer
29,159
0.0168%
$0.45$13,241+0.25%
2024-11-15PurchaseX4 Pharmaceuticals, Inc.
XFOR
Chief Commercial Officer
13,404
0.0068%
$0.34$4,598+21.09%
2024-10-07SaleX4 Pharmaceuticals, Inc.
XFOR
Chief Commercial Officer
11,127
0.0059%
$0.58$6,506-4.44%
2024-05-17PurchaseX4 Pharmaceuticals, Inc.
XFOR
Chief Commercial Officer
21,646
0.009%
$0.68$14,654-33.29%
2023-11-01SaleX4 Pharmaceuticals, Inc.
XFOR
Chief Commercial Officer
10,257
0.006%
$0.73$7,488+9.27%
Total: 5
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.